COP:TRIN
  • HOME
  • ABOUT
    • VISION
    • ORGANISATION
      • ADMINISTRATIVE LEADERS
      • STEERING COMMITTEE MEMBERS
      • ADVISORY BOARD
      • PROJECT GROUP
      • CLOSE COLLABORATORS
      • MAP OF COLLABORATORS
    • MINUTES
  • TRIALS
  • EPIDEMIOLOGY
    • CURE
  • ALPHA-1
  • PLEURA
  • PUBLICATIONS
  • NEWS
  • CALENDAR
    • UPCOMING MEETINGS
    • PREVIOUS MEETINGS
  • CONTACT
logo

News

  • Svær KOL skal behandles med prednisolon i blot et par dage
    Stor dansk sammenfatning af tidligere studier viser, at der er yderligere at hente i forhold til at reducere længden på...
    READ MORE →
  • Methotrexat reducerer risiko for KOL-forværring
    Et dansk registerstudie præsenteret på ERS viser, at behandling med methotrexat meget markant reducerer risikoen for KOL-forværring. Resultatet lægger grundstenene...
    READ MORE →
  • Eosinofil-styret OCS-behandling til patienter med KOL fungerer – også blandt rygere
    En netop publiceret post-analyse af studiet CORTICO-COP med fokus på patienter med KOL, der ryger eller har røget, peger på,...
    READ MORE →
  • Hydroxyklorokin har ingen effekt på covid-19-patienter
    Et dansk studie viser, at hydroxyklorokin i kombination med azithromycin ikke har positiv effekt på patienter med covid-19, men det...
    READ MORE →
  • Akutte KOL-forværringer kan potentielt behandles i løbet af 2-5 dage
    Et nyt studie peger i retning af, at patienter med KOL med akutte forværringer kan nøjes med en to til...
    READ MORE →
  • Ny forskning skal reducere brug af ­inhaleret binyrebarkhormon ved KOL
    En bevilling på 10 mio. kr. skal bane vej for at identificere KOL-patienter, som har gavn af lokal vedligeholdelses­behandling med...
    READ MORE →
  • Nu tester danske forskere for første gang effekten af klorokin og antibiotika på COVID-19-patienter
    Studiet, der begynder nu, skal afklare om en kombination af antibiotika og malariamedicinen hydroxyklorokin kan hjælpe patienter med COVID-19. Forsøget...
    READ MORE →
  • Det er tid til at indføre ny behandlingsform ved forværring af KOL
    Read more here...
    READ MORE →
  • Bakterie forringer sygdomsudfaldet ved KOL
    Read more here...
    READ MORE →
  • På sporet af den rette behandling af svært syge KOL-patienter
    Read more here...
    READ MORE →
  • Enkel blodprøve kan halvere forbruget af binyrebarkhormon
    Read more here...
    READ MORE →
  • Welcome to the new COP:TRIN homepage
    We have chosen to update our website and the website now includes a calendar with upcoming meetings and events.

    As part of the update the site has changed web address to coptrin.dk...
    READ MORE →
  • Copenhagen Unit for Respiratory Epidemiology (CURE)
    Copenhagen Unit for Respiratory Epidemiology (CURE) will perform state-of-the-art epidemiological research based in Danish national health registers to answer current...
    READ MORE →
  • Introduction to Copenhagen Unit for Respiratory Epidemiology (CURE)
    We would like to introduce Copenhagen Unit for Respiratory Epidemiology (CURE). CURE will perform state-of-the-art epidemiological research based in Danish national health registers to answer current important questions regarding patients with chronic pulmonary diseases like COPD and interstitial lung diseases. CURE is the epidemiological branch of COP:TRIN. ...
    READ MORE →
  • Forskernetværk vil gå uden om industrien for at hjælpe KOL-patienter
    Læs mere her (kræver abonnement på Dagens Medicin)...
    READ MORE →
  • KOL-forskere: Det er gammeldags at skyde med spredehagl
    Læs mere her (kræver abonnement på Dagens Medicin)...
    READ MORE →
  • Lægen, der vil netværke mod KOL
    Læs mere her (kræver abonnement på Dagens Medicin)...
    READ MORE →
Design and development by: Hjemmeside til forening | Login
Back to Top
COP:TRIN.DK BENYTTER SIG AF COOKIES

Denne hjemmeside benytter sig af cookies, som husker dine tidligere handlinger. På denne måde bliver det hurtigt og nemt for dig at navigere rundt.

Cookie-politik


Accepter
Mere om cookies

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT